Live Quote · NYSENVOHealthcare· Drug Manufacturers - General

Novo Nordisk A/S

$37.82▼ 2.70%($-1.05)
MKT CAP $169.23BNEXT EARNINGS Feb 3, 2027
50%
Bullish
TickerSpark Score
64/100
▌ Mixed
83
Valuation
100
Profitability
50
Growth
56
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NVO research report →

Analyst Price Target
$42.33+11.9% vs. today

Range $40 – $47

Analyst RatingBuy
23 Buy13 Hold3 Sell

Price Chart

-20.55% · this period
$63.98$49.63$35.29Nov 20May 26Nov 20
52-Week Range9% of range
Low
$35.12
Current
$37.82
High
$64.16